These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase. Fei X, Zhang P, Pan Y, Liu Y. Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170 [Abstract] [Full Text] [Related]
7. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma. Zhang C, Chen B, Jiao A, Li F, Sun N, Zhang G, Zhang J. BMC Cancer; 2018 Nov 28; 18(1):1179. PubMed ID: 30486878 [Abstract] [Full Text] [Related]
8. circ-PRKCI targets miR-1294 and miR-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma. Chen W, Li Y, Zhong J, Wen G. Mol Med Rep; 2021 Jun 28; 23(6):. PubMed ID: 33880589 [Abstract] [Full Text] [Related]
10. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1. He Y, He X. Yonsei Med J; 2019 Mar 28; 60(3):267-276. PubMed ID: 30799589 [Abstract] [Full Text] [Related]
12. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma. Zhou Q, Zhang W, Wang Z, Liu S. BMC Cancer; 2019 Jul 24; 19(1):731. PubMed ID: 31340767 [Abstract] [Full Text] [Related]
13. MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma. Ding W, Tan H, Li X, Zhang Y, Fang F, Tian Y, Li J, Pan X. Cancer Biomark; 2018 Jul 24; 22(3):427-434. PubMed ID: 29758928 [Abstract] [Full Text] [Related]
18. Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma. Zhao X, Chen GQ, Cao GM. Eur Rev Med Pharmacol Sci; 2019 Aug 24; 23(16):6888-6898. PubMed ID: 31486488 [Abstract] [Full Text] [Related]
19. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29. Du H, Xu Q, Xiao S, Wu Z, Gong J, Liu C, Ren G, Wu H. Life Sci; 2019 May 01; 224():1-11. PubMed ID: 30876939 [Abstract] [Full Text] [Related]